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of 8% oxygen for 10 days. I then compared the two groups in the following categories 
to characterize differences in DNA damage levels and disease severity: hemodynamic 
measurements of right ventricular systolic pressure (RVSP), left ventricular end 
diastolic pressure (LVEDP), complete blood count (CBC); quantification of DNA 
damage; and the number of (muscularized) small pulmonary arteries. Contrary to my 
expectations, I found a higher trend of RVSP in the wild-type mice, a greater amount of 
DNA damage in the knock-out mice that was only slightly significant, no significant 
difference in the number of small pulmonary arteries between the two groups of mice, 
and a significantly greater amount of fully muscularized small pulmonary arteries in the 
wild-type mice. These results do not support the notion that DNA damage in pulmonary 
arterial endothelial cells is a causal factor of the progression of pulmonary arterial 
hypertension, but the limitations of the experimental design and potential improvements 
must be considered before coming to a definite conclusion. 
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Significance 
Pulmonary Arterial Hypertension 
Pulmonary hypertension is a form of high blood pressure that affects pulmonary 
arteries, or the arteries in the lungs, of which pulmonary arterial hypertension is a 
subset. It can be clinically diagnosed by an elevation of mean pulmonary arterial 
pressure above 25 mmHg at rest or 30 mmHg with exercise; according to the American 
Heart Association, normal pulmonary arterial pressure is about 14 mmHg (12). 
Symptoms during the initial phase, however, are not unique to the disease, such as 
fatigue and difficulty breathing, so the disease is usually not detected in patients until 
more severe symptoms are manifest, such as chest pain and palpitations. This range in 
severity is described by the four functional classes of the disease, from Class I with 
patients showing no symptoms during physical activity to Class IV with patients 
suffering from fatigue or shortness of breath from right heart failure even while resting 
– this last class has the highest mortality rate out of the four (16). Although there are 
treatments available, there is currently no cure. 
 The pathology of pulmonary arterial hypertension has been characterized in 
considerable detail.  The development of the disease contributes to changes in the 
pulmonary arteries that cause high resistance to blood flow from the heart to the lungs. 
Specific pathological effects include the following (see Figure 1): muscularization of 
pulmonary arteries, medial hypertrophy of muscularized arteries, obliterative neointimal 
lesions, loss of small pre-capillary arteries, and plexiform lesions (12). The 
muscularization of the pulmonary arteries occurs as a result of the differentiation of 
pericytes, or contractile cells that envelop endothelial cells lining the inner blood vessel,   
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Figure 1. An illustrative overview of pulmonary arterial hypertension pathology. 
Vascular abnormalities that occur as a result of the disease are shown (12). 
 
into smooth muscle cells that then proliferate. The continuous proliferation and 
migration of smooth muscle cells lead to two serious pathological effects of the disease 
by thickening the layer of the arteries: medial hypertrophy of muscularized arteries and 
neointimal lesions. Neointima refers to the new layer formed in the innermost lining of 
blood vessels that results from inflammatory cell signaling and injured endothelial cells 
that lead to the proliferation of smooth muscle-like cells, or cells resembling smooth 
muscle cells. Small pre-capillary arteries are lost through apoptosis, or programmed cell 
death, of endothelial cells and/or pericytes, while plexiform lesions, a marker of severe 
pulmonary arterial hypertension in the form of blocked pulmonary arteries with 
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abnormal channels, are due to the eventual, unregulated proliferation of endothelial 
cells.  
Genetics has a crucial role in the pathology of pulmonary arterial hypertension. 
A significant genetic cause of pulmonary arterial hypertension in 70% or more of 
patients with hereditary pulmonary arterial hypertension and 10-20% of patients with 
idiopathic pulmonary arterial hypertension has been identified as a haploinsufficiency, 
or a condition of having one functional copy out of two for a particular gene, of the 
bone morphogenetic protein receptor 2 (BMPR2) gene or defective bone morphogenetic 
protein (BMP) signaling (12). BMPR2 is a protein belonging to the TGF-β family of 
growth factor receptors and normally signals through multiple pathways. This 
haploinsufficiency or defective signaling leads to endothelial cell dysfunction, which 
explains both the apoptosis responsible for the loss of pulmonary arterial micro-vessels 
and the failure of pulmonary arterial endothelial cells to control the proliferation and 
migration of smooth muscle-like cells that lead to lumen occlusion and vascular 
resistance. Under normal conditions, BMP stimulation promotes endothelial cell 
survival through downstream activation of a receptor in the cell nucleus called 
peroxisome proliferator-activated receptor-γ (PPARγ) that is crucial for the maintenance 
of vascular stability (see Figure 2). The formation of a complex in the nucleus between 
PPARγ and another protein called β-catenin initiates transcription, or the first step to the 
conversion of a gene into a protein, of a pro-survival gene called apelin. This promotes 
the necessary endothelial cell proliferation and migration for angiogenesis and inhibits 
proliferation of pulmonary arterial smooth muscle cells (1). The other pathway 
beginning from BMPR2 depends on PPARγ as a transcriptional activator of apoE, a 
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gene that inhibits PDGF-BB-mediated smooth muscle cell proliferation and migration 
(9). Without BMPR2 function or BMP signaling, these pathways do not occur, thus 
leading to the characteristics of the disease.  
 
Figure 2. Overview of the BMPR2 pathway. Downstream, the transcription of genes 
necessary for angiogenesis and inhibition of smooth muscle cell proliferation and 
migration occurs. 
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Question and Hypothesis 
Further evidence centered on PPARγ have shown a connection between the 
regulation of DNA stability and the pathology of pulmonary arterial hypertension. In 
lung tissues of human patients with pulmonary arterial hypertension, studies have 
shown a reduced expression of PPARγ, which is highly expressed in normal pulmonary 
arterial endothelial cells (4). Rabinovitch et al. have looked into this finding and found 
two significant effects of this reduction in PPARγ: extensive unrepaired DNA damage 
and a worsened disease phenotype. They have discovered significantly more unrepaired 
DNA damage in the pulmonary arterial endothelial cells of patients than in those of 
donor controls using an experimental technique called the comet assay, which allows 
for the measurement of DNA breaks in eukaryotic cells. This can be explained by 
current studies in the lab that are uncovering interactions between PPARγ and DNA 
damage sensing proteins, one of which is the MRN complex (see Figure 3), and by 
further studies that have shown through the comet assay that PPARγ knock-down 
impairs the DNA Damage Response (DDR) activation and reduces DNA repair capacity 
in pulmonary arterial endothelial cells.  
A separate study found significant differences in the severity of pulmonary 
arterial hypertension between mice with endothelial cell-specific deletion of PPARγ and 
wild-type mice after recovery from hypoxia, a condition of oxygen deficiency (8). In 
short, the absence of PPARγ results in both significant unrepaired DNA damage and a 
worsened disease phenotype, which leads to the following question: Does an 
accumulation of DNA damage in pulmonary arterial endothelial cells contribute to the 
progression of pulmonary arterial hypertension?  
 6  
To investigate into the posed question, I propose that extensive, unrepaired 
DNA damage in pulmonary arterial endothelial cells leads to endothelial cell 
dysfunction and worsening pulmonary arterial hypertension. 
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Specific Aims 
Specific Aim 1 
Determine if endothelial cell-specific deletion of Mre11 in a transgenic mouse 
model leads to persistent DNA damage. 
Rationale 
In more than half of nine examined human patients within a study, somatic 
chromosomal mutations in pulmonary arterial endothelial cells have been identified, 
signifying a link between genomic instability and the disease (2). In addition, as 
previously mentioned, studies done in the Rabinovitch lab showing unrepaired DNA 
damage in pulmonary arterial endothelial cells with PPARγ knock-down point to the 
same conclusion. As a result, it is clear that the DDR pathway is crucial within the 
model of pulmonary arterial hypertension. 
A crucial component of this study is the MRN complex, which functions as a 
DNA damage sensor. Consisting of proteins called Meiotic Recombination 11  
 
Figure 3. Depiction of the MRN complex, consisting of MRE11, NBS1, and RAD50. 
MRE11 directly binds to the DNA to carry out its functions (13). 
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(MRE11), Radiation sensitive 50 (RAD50), and Nijmegen breakage syndrome 1 
(NBS1), the complex physically localizes to sites of damage quickly once it senses 
DNA damage (see Figure 3). The other significant functions of the complex (see Figure 
4) include governing the activation of ATM, a kinase–a phosphorylating protein–that 
primarily controls responses to double-stranded DNA breaks, and ATR, a kinase 
primarily recruited to single-stranded DNA breaks (5,13). ATM and ATR then 
phosphorylate and activate downstream factors, such as CHK1, CHK2 and H2AX (5). 
Activated CHK1 or CHK2 then dissociates from the DNA and phosphorylates p53, a 
protein regulator of the cell cycle that functions as a tumor suppressor. This leads to 
transcription of p21, a strong regulator of the cell cycle progression that arrests the cell 
cycle to allow repair of DNA damage. γH2AX, or H2AX phosphorylated by ATM and 
ATR, forms the focus for recruitment of DNA repair proteins, such as BRCA. 
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Figure 4. Overview of the DNA Damage Response (DDR) pathway. The lightning 
symbol represents DNA damage, from which the MRN complex activates downstream 
effectors of DNA damage repair. Studies have discovered interactions between PPARγ 
and the MRN complex. 
 
This study will focus on MRE11, one of the three proteins of the MRN complex 
(see Figure 3). Within the DDR pathway, it functions both as an endonuclease that cuts 
single-stranded DNA and an exonuclease that cuts double-stranded DNA in one 
direction. Like the other two components of the MRN complex, MRE11 is essential for 
viability, as verified by the early deaths during embryogenesis of transgenic mice, or 
mice with modified genomes, whose Mre11, Rad50, or Nbs1 gene had been deleted 
(13). The purpose of this specific aim is to generate and verify the accumulation of 
DNA damage through endothelial cell-specific deletion of Mre11 in transgenic mice in 
order to investigate the role of DNA damage in the pathology of pulmonary arterial 
hypertension. 
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Experimental Design 
A) Mice 
The transgenic mice used in this study have been engineered to express a tamoxifen-
inducible protein called CreER recombinase, whose expression is driven by the 5’ 
endothelial enhancer of the stem cell leukemia (SCL) locus. For the purpose of this 
experiment, the SCL 5’ endothelial enhancer was used to direct the expression of 
CreER recombinase to endothelial cells, so that the protein would function only in 
endothelial cells (7). Attached to the CreER recombinase is a ligand-binding domain of 
estrogen receptor (ER) that binds to tamoxifen, an estrogen antagonist, resulting in the 
entry into the nucleus where the recombinase functions. Genetic crosses between two 
breeds of mice created the “knock-out” progeny we used: one breed consisted of a 
transgene with the 5’ endothelial enhancer region of the SCL locus genetically 
engineered with the CreER recombinase gene and the ligand-binding domain of ER, so 
that upon injection of tamoxifen, CreER recombinase enters the nuclei of endothelial 
cells, and the other breed consisted of a transgene with Mre11 flanked by two LoxP 
sites that are recognized by CreER for deletion (see Figure 5). In this way, the Mre11 is 
conditionally inactivated in endothelial cells in the transgenic knock-out mice upon 
tamoxifen delivery at the desired age. The gene containing Mre11 in the wild-type 
mice, on the other hand, does not contain the LoxP sites, which explains the Mre11 
expression regardless of the type of cell (see Figure 6). Five male wild-type mice with 
the genotype SCL-Cre-Mre11+/+ and five male knock-out mice with the genotype SCL-
Cre-Mre11cond/cond were used for this study.  
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Figure 5. A depiction of Cre-lox recombination using CreER. CreER recombinase 
expression occurs in specific cells to where the fused promoter drives expression, and 
after binding to tamoxifen, the protein enters the nucleus where it deletes genes flanked 
by two loxP sites, resulting in a specific knock-out (10). 
 
 
Figure 6. Depiction of the SCL-Cre-Mre11 transgenes for knock-out and wild-type 
mice. The two LoxP sites are shown in the Mre11cond knock-out, where the CreER 
recombinase binds to upon its activation by tamoxifen, resulting in the excision of the 
area enclosed by the LoxP sites and the consequent deletion of Mre11, as shown by the 
dark region. The Mre11+ wild-type gene does not include LoxP sites (5). 
 
For two weeks on a daily basis before the mice were used, tamoxifen solution 
(10 mg/mL dissolved in corn oil) was injected into all mice when they were between 10 
and 13 weeks old in order to activate the cell-specific gene expression of CreER 
recombinase in the cells. Then the mice were placed under conditions of hypoxia (8% 
O2) for ten days to induce DNA damage instead of other damaging agents since 
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moderately hypoxic environments are characteristic of pulmonary arterial hypertension. 
In addition, it is known that moderate hypoxia activates the DDR pathway in 
endothelial cells (11). 
B) DDR Pathway Evaluation 
After the mice were euthanized, a total of 3 thin samples from the distal, middle, 
and proximal sections of lung tissues were placed on a microscope slide for each 
mouse, from which lung histology was carried out to analyze evidence of DNA damage 
in the pulmonary arteries. The indirect method of immunohistochemistry was used on 
the lung tissues to identify certain tissue components through two sets of interactions: 
one between a primary antibody and its target antigen and another between a secondary 
antibody conjugated with a fluorescent tag and the primary antibody (see Figure 7). In 
this part of the study, a fluorescent blue stain called DAPI for nuclei was used, as well 
as two sets of primary and secondary antibodies to identify specific antigens: rabbit von 
Willebrand Factor (vWF) and green-tagged secondary anti-rabbit antibody for the 
endothelial cells, and mouse γH2AX and red-tagged anti-mouse antibody for DNA 
damage. The antibodies vWF and γH2AX were used because vWF is a blood clotting 
protein made within endothelial cells and γH2AX is a histone variant that is 
phosphorylated upon the generation of double-stranded breaks, a form of DNA damage. 
Pictures of the prepared tissue samples were taken using a fluorescence microscope in 
the lab.  
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Figure 7. An example depicting the indirect method of detecting target antigen in 
immunohistochemistry (14). 
 
To quantify DNA damage, small pulmonary arteries were first identified from 
the pictures taken with the microscope, using a systematic approach blinded to whether 
the mouse was wild-type or knock-out. On a program called ImageJ that is typically 
used for visual analysis of fluorescently marked cells, merging the fluorescent blue 
DAPI, green vWF, and red γH2AX markers allowed for the counting of small 
pulmonary arteries with DNA damage within the size range of a 20-50µm diameter and 
located below the respiratory bronchioles level and along the alveolar ducts (see Figure 
8). The inclusion criteria for a small pulmonary artery with DNA damage required at 
least having 2-3 nuclei of endothelial cells and at least one red-tagged γH2AX marker 
located within an endothelial cell nucleus. Results from wild-type and knock-out mice 
were analyzed using an unpaired t-test via a computer program called Prism. 
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Figure 8. Sample pictures of fluorescently marked lung tissues taken on the 
fluorescence microscope using the markers vWF, γH2AX, and DAPI. The picture on 
the left represents an artery with no DNA damage, as indicated by the lack of the red 
marker, and the picture on the right represents an artery with DNA damage, as indicated 
by the circles surrounding red markers in the nuclei. Both arteries shown have at least 3 
nuclei of endothelial cells (blue DAPI flanked by green vWF).  
 
Results and Discussion 
As expected, there were significantly more pulmonary arteries with DNA 
damage in the knock-out mice than in the wild-type mice (see Figure 9). Only 3 wild-
type and 3 knock-out mice were used for the counting due to time constraints associated 
with taking pictures of the lung tissues using the fluorescence microscope. There was 
greater consistency in the amount of DNA damage in the knock-out mice than in the 
wild-type mice, but the fact that the difference in the amounts of DNA damage between 
the two groups of mice is only slightly significant must be considered. The p-value from 
the unpaired t-test was 0.0344, which is only slightly less than 0.05. We had expected 
the Mre11-knock-out mice to have a substantially greater amount of DNA damage than 
the wild-type mice due to their loss of a crucial DNA damage sensing protein, but our 
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unexpected result can be explained for by the possibility that the hypoxic conditions of 
8% oxygen may have been too severe for all mice–in other studies, 10% was used (8). 
 
Figure 9. Results of DNA damage amounts in wild-type (WT) and knock-out (KO) mice in percentage 
are shown in a graph–γH2AX positive arteries refer to arteries with DNA damage. There were 
significantly more pulmonary arteries with DNA damage in the knock-out mice than in the wild-type 
mice with a p-value of 0.0344 from the unpaired t-test done by Prism. The raw data are shown in a table. 
 
This could have led to similarly extensive DNA damage across all mice, regardless of 
genotype. Our results can be alternately explained for by the small total sample size of 6 
mice or by inaccurate counting of γH2AX-positive arteries. It is unlikely that the SCL-
CreER system failed to activate the specific deletion of Mre11, since we have obtained 
consistently high amounts of DNA damage in the knock-out mice.  
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Specific Aim 2 
Characterize the effects of endothelial cell-specific deletion of Mre11 on 
pulmonary vasculature to observe induced symptoms of pulmonary arterial 
hypertension. 
Rationale 
This specific aim lies at the heart of this research, for its primary purpose is to 
identify whether accumulation of DNA damage results in worsened pulmonary 
vasculature, or pulmonary arterial hypertension. As mentioned previously, findings 
from the Rabinovitch lab that uncover two potential correlations between reduced 
PPARγ expression and unrepaired damaged DNA and between reduced PPARγ 
expression and pulmonary arterial hypertension support this aim.  
Experimental Approach 
A) Mice 
The same transgenic mice from Specific Aim 1 were used for this aim. 
B) Hemodynamic Measurements 
The following hemodynamic measurements were taken of the mice: right 
ventricular systolic pressure (RVSP), left ventricular end diastolic pressure (LVEDP), 
and a complete blood count (CBC). RVSP, or the pressure in the right ventricle when 
the heart contracts, was measured for the mice because it is generally increased in 
patients with pulmonary arterial hypertension. LVEDP, or the pressure in the left 
ventricle at the end of the heart’s resting period between contractions, was also 
measured in order to rule out contributions from the left ventricle when analyzing the 
outcomes of the mice. RVSP and LVEDP measurements were obtained simultaneously 
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by a closed-chest technique that took measurements on a computer program via a 
catheter in the jugular vein of the mice under anesthesia. The CBC was carried out by a 
laboratory within the Stanford facilities that analyzed blood samples–the purpose of this 
was to measure the effects of hypoxia on the mice that can be then further analyzed and 
understood. This included three groups: red blood cells, white blood cells, and platelets. 
To analyze how the mice responded to reduced oxygen, the measurements of red blood 
cells included red blood cells, hemoglobin (oxygen-carrying protein in red blood cells), 
hematocrit (the ratio of the volume of red blood cells to the total volume of blood), and 
absolute reticulocyte (immature red blood cells). For the purpose of gauging the health 
of the mice, the measurements of white blood cells included white blood cells, absolute 
neutrophil, absolute lymphocyte, and absolute monocyte. Platelet count was merely 
included in the CBC without relevance to the study. 
C) Lung Histology 
Indirect immunohistochemistry was the primary method used for the counting of 
(muscularized) small pulmonary arteries to assess the loss and the muscularization of 
small pulmonary arteries. In this part of the study, fluorescent blue DAPI for nuclei was 
used, as well as two sets of primary and secondary antibodies to identify specific 
antigens: rabbit vWF and green-tagged secondary anti-rabbit antibody for the 
endothelial cells, and mouse α-smooth muscle actin (SMA) and red-tagged anti-mouse 
antibody for the muscularized cells. Pictures of the prepared tissue samples were taken 
using a fluorescence microscope in the lab. 
The numbers of small pulmonary arteries and of muscularized small pulmonary 
arteries were counted from the images taken with the microscope, using a systematic 
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approach blinded to whether the mouse was wild-type or mutant. First, a total of five 
respiratory zones consisting of respiratory bronchioles, alveolar ducts, and alveoli were 
located for each mouse (see Figure 10). Next, to maintain consistency for each tissue  
 
 
Figure 10. Depiction of a respiratory zone and its components, including respiratory 
bronchioles, alveolar duct, and alveoli. An image of a mouse lung tissue section is 
shown (15). 
 
portion, a section enclosing 100 alveoli surrounding alveolar ducts was determined for 
each respiratory zone, from which the small pulmonary arteries were counted. The 
alveoli were counted by converting the images into black-and-white to facilitate the 
counting process (see Figure 11). Then with the use of the ImageJ program, small 
pulmonary arteries marked by the green vWF marker for endothelial cells within a 20-
50µm diameter and located below the respiratory bronchioles level and along the 
alveolar ducts were then counted. An average was taken for each mouse. Out of the 
small pulmonary arteries that were counted, the muscularized ones were counted by 
merging the green vWF and red SMA markers on ImageJ, with the level of 
muscularization ranging from none to partially to fully muscularized. No 
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muscularization would be indicated by a lack of red, partial muscularization by an 
incomplete red lining of the artery, and full muscularization by a complete red lining of 
the artery. Finally, the differences between the counts of small pulmonary arteries for 
wild-type and for knock-out mice were analyzed with an unpaired t-test, and the 
differences between the counts of fully muscularized small pulmonary arteries for wild-
type and for knock-out mice and between the counts of partially muscularized small 
pulmonary arteries for wild-type and for knock-out mice were analyzed with one-way 
ANOVA via the Prism program.  
 20  
 
 
 
Figure 11. Sample pictures of fluorescently marked lung tissues taken on the 
fluorescence microscope using the markers vWF, SMA, and DAPI. Each of the two 
groups of images shown include a merged picture of all markers on the left and 4 
pictures on the right that display how the (muscularized) small pulmonary arteries and 
alveoli were counted. The top group of images is from a wild-type mouse, and the 
bottom group from a knock-out mouse.  
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Results and Discussion 
A) Hemodynamic Measurements 
1. RVSP and LVEDP – No significant differences were observed in both the 
RVSP and LVEDP measurements between the wild-type and knock-out mice, but 
general trends were noted (see Figure 12). RVSP measurements of only 4 wild-type and 
4 knock-out mice rather than 5 for each group were taken due to complications with one 
wild-type mouse during the measuring procedure and the death of one knock-out mouse 
after 10 days of hypoxia. Contrary to our expectations, the average of the RVSPs of the 
wild-type mice was higher than that of the knock-out mice. We had expected greater 
 
Figure 12. Graphs of RVSP and LVEDP measurements with averages of each group shown. There were 
no significant differences between wild-type and knock-out mice for RVSP and LVEDP. Normal range of 
RVSP is below 25 mmHg during rest and of LVEDP is between 0-10 mmHg. There were 4 wild-type 
mice used for both RVSP and LVEDP measurements, while for knock-out mice, 4 were used for RVSP 
and 2 for LVEDP measurements. 
 
RVSPs in the knock-out mice than in the wild-type mice, since we anticipated that 
unrepaired DNA damage caused by lack of Mre11 would make the mice more 
susceptible to characteristics of pulmonary arterial hypertension, such as an elevated 
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RVSP. In the knock-out mice, the deletion of Mre11 in endocardial cells could have 
influenced the results somehow. Both groups of mice, however, had average RVSPs 
greater than the normal 25 mmHg, suggesting that the hypoxic conditions did affect the 
pulmonary vasculature. For the LVEDP measurements, only 4 wild-type and 2 knock-
out mice were used due to unexpected deaths during the procedure. The average 
LVEDP measurements for both groups of mice, however, did not differ very much and 
were within the normal range of LVEDP of 0-10 mmHg, suggesting that the left 
ventricle was not greatly affected by hypoxia. 
ii. CBC – To analyze further how the mice responded to hypoxia, we took blood 
samples from 4 wild-type and 4 knock-out mice and processed a complete blood count 
for each mouse. Within the group of results pertaining to red blood cells–red blood 
cells, hemoglobin, hematocrit, platelet count, and absolute reticulocyte–the wild-type 
mice generally had higher averages than the knock-out mice, except for red blood cells 
which both groups had an average of around the same amount (see Figure 13). The 
wild-type mice had significantly greater averages of hematocrit and absolute 
reticulocyte than the knock-out mice. The hematocrit results could indicate that the 
wild-type mice generally had less blood volume than the knock-out mice because the 
red blood cell averages are similar for both groups, and the absolute reticulocyte results 
could indicate that the wild-type mice responded more severely than the knock-out mice 
to hypoxia by producing red blood cells more quickly. At the time the blood samples 
were taken, it is possible that this difference in rate of red blood cell production was not 
translated into a difference in red blood cell count because the reticulocytes had yet to 
mature. Another possible explanation can be made with the fact that the Scl-CreER 
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system functions in hematopoietic cells in addition to endothelial cells, which could 
have negatively affected the amount of reticulocytes in the knock-out mice. Despite 
their differences, both groups of mice had amounts of red blood cells, hemoglobin, and 
hematocrit higher than the normal range, suggesting that they responded to the low-
oxygen environment by making more red blood cells than they would have under 
normal oxygen levels. This supports the sufficiency of the 10-day long hypoxia period 
in initiating a cellular response in the mice. 
  
Figure 13. Graphs of CBC results for 4 wild-type and 4 knock-out mice. Here shown 
are red blood cell, hemoglobin, hematocrit, platelet count, and absolute reticulocyte 
results, all representative of red blood cells. Reference ranges are shown for each group 
except for absolute reticulocyte, for none was given. Wild-type mice had averages of 
hematocrit and absolute reticulocyte significantly greater than those of knock-out mice 
with a p-value less than 0.05. For both wild-type and knock-out mice, amounts of red 
blood cells, hemoglobin, and hematocrit were higher than the normal range. 
 
Within the group of results pertaining to white blood cells–white blood cells, 
absolute neutrophil, absolute lymphocyte, and absolute monocyte–only the absolute 
neutrophil count was significantly greater in the knock-out mice than in the wild-type 
mice (see Figure 14). This is due to the abnormal low amount of neutrophils in the wild-
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type mice. For both mice, white blood cell and absolute lymphocyte counts were 
noticeably lower than the normal range, suggesting either that the mice became infected 
by some means that led to the destruction of white blood cells or that they were merely 
susceptible to infection. Wild-type mice seem to have been more at risk of infection and 
unable to protect themselves efficiently in comparison to knock-out mice.  
 
Figure 14. Graphs of more CBC results of 4 wild-type and 4 knock-out mice. Here 
shown are white blood cell, absolute neutrophil, absolute lymphocyte, and absolute 
monocyte results, all representative of white blood cells. Reference ranges are shown 
for each group. Knock-out mice had a significantly higher average of absolute 
neutrophil than that of wild-type mice with a p-value less than 0.05. White blood cell 
and absolute lymphocyte counts were lower than the normal range for both groups of 
mice, while absolute neutrophil counts were lower than the normal range for only wild-
type mice. 
 
B) Lung Histology 
 After counting was finished, the number of small pulmonary arteries and the 
number of fully and partially muscularized small pulmonary arteries respectively for 
wild-type and knock-out mice were compared (see Figure 15). There was no significant 
difference between the averages of small pulmonary arteries in wild-type and knock-out 
mice–we had expected there to be more small pulmonary arteries in the wild-type than 
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in the knock-out mice, or for the disease phenotype to be more severe in knock-out than 
in wild-type mice. Our results could be due to the short 10-day period of hypoxia or due  
 
Figure 15. Graphs of results from counting small pulmonary arteries and muscularized 
small pulmonary arteries for 5 wild-type mice and 4 knock-out mice. The averages of 
small pulmonary arteries in wild-type and knock-out mice were very similar. Wild-type 
mice had significantly more fully muscularized small pulmonary arteries than knock-
out mice, while knock-out mice had significantly more partially muscularized small 
pulmonary arteries than wild-type mice.  
 
to our method of choosing 5 respiratory zones as opposed to using every respiratory 
zone for each mouse. As for the muscularized small pulmonary arteries, the average of 
fully muscularized small pulmonary arteries in the wild-type mice was significantly 
greater than the average in the knock-out mice contrary to what we expected, and the 
average of partially muscularized small pulmonary arteries in the knock-out mice was 
significantly greater than the average in the wild-type mice as we expected. The results 
for fully muscularized small pulmonary arteries align with the RVSP results, however: 
it is possible that the greater muscularization of the small pulmonary arteries in the 
wild-type mice is correlated with the higher RVSP trend. The muscularization signifies 
more effort than normal in pumping the blood through the arteries, which would be 
connected with a high RVSP since the right ventricle pumps blood through the 
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pulmonary arteries. The reason for the greater amount of full muscularization in the 
wild-type mice than in the knock-out mice can only be speculated; the knock-out mice 
seemed to have a slower physiological response than the wild-type mice. One thing for 
certain, however, is that the results representative of red blood cells cannot serve as an 
explanation, for a study has shown that in hypoxic mice the increased muscularity of 
pulmonary arteries is independent of elevation of hematocrit; in other words, vascular 
remodeling models are not correlated with blood results (5). The wild-type mice must 
have fared more poorly in hypoxic conditions than the knock-out mice, but why this is 
so is uncertain.  
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Conclusion 
In conclusion, my results did not support my hypothesis, or more specifically, 
that accumulation of DNA damage leads to worsened pulmonary arterial hypertension. 
As expected, there was significantly more DNA damage as indicated by the γH2AX 
marker in the pulmonary arterial endothelial cells of the knock-out mice than of the 
wild-type mice, but the significance was small. The RVSPs of the wild-type mice were 
generally higher than that of the knock-out mice, but for both groups the values were 
higher than normal suggesting that some vascular remodeling took place in response to 
the 10 days of hypoxia. The LVEDP values were similar and within the normal range, 
suggesting that the remodeling did not affect the left side of the heart in both groups. 
With a general trend of higher amounts in the wild-type mice than in the knock-out 
mice, the counts representative of red blood cells were significantly different for 
hematocrit and absolute reticulocyte, perhaps meaning that the blood volume was less 
and that red blood cell production was faster in the wild-type mice than in the knock-out 
mice. Overall, however, both groups of mice responded to hypoxia by increasing red 
blood cell production to more than what is considered normal. On the contrary, the 
counts representative of white blood cells showed a significant difference in absolute 
neutrophil amounts between both groups, wild-type mice having an abnormally low 
amount and knock-out mice having a normal but significantly greater amount than the 
wild-type mice. Both groups had abnormally low amounts of white blood cells and 
lymphocytes, suggesting that the mice were susceptible to infection. Whether this 
occurred from the hypoxic conditions or from an infection that the mice caught by some 
means remains to be known. There was no significant difference in the amounts of 
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small pulmonary arteries; the disease phenotype of loss of pulmonary arteries was not 
observed in the knock-out mice. The wild-type mice had significantly more fully 
muscularized arteries than the knock-out mice, but the knock-out mice had significantly 
more partially muscularized arteries. These results suggest that the wild-type mice 
developed the disease characteristic of muscularized arteries more so than the knock-out 
mice, which correlates with the RVSP values. Although these findings seem to disprove 
my hypothesis, further research is required to confirm what I have found. 
There were a number of limitations to this study that may have caused 
unexpected results. First, the period of 10 days of hypoxia may have been too short for 
the DNA damage to translate into the expected resulting pathology in the knock-out 
mice–other studies have used a period of hypoxia of 3 weeks (6, 8). This could result in 
a lack of a significant difference between the wild-type and knock-out mice in the 
amounts of DNA damage and severity of the pathology. Ten days was chosen, however, 
because of the unexpected death of one of the knock-out mice and the uncertainty over 
additional following deaths. Second, no measurements of the mice were taken before 
hypoxia to set a baseline to which the results from the hypoxic period could be 
compared. Third, a period of re-oxygenation was not included after hypoxia, which 
could have confirmed a difference between the wild-type and knock-out mice in the 
way that they recover from the DNA damage induced by hypoxia. Fourth, the sample 
size of this study may have been too small for various parts, ranging from 6 to 9 mice 
throughout. Fifth, the SCL-CreER system used to knock-out the Mre11 gene may not 
have been specific enough to endothelial cells, since the SCL 5’ endothelial enhancer 
region also directs gene expression to early hematopoietic progenitor cells (7). This 
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inability to restrict the conditional inactivation of Mre11 to endothelial cells must be 
taken into consideration, for it could have led to unforeseen effects by inducing more 
stress upon the mice than had been intended. It is possible that knock-out of Mre11 in 
early hematopoietic progenitor cells could be related in some way to the significantly 
fewer amount of absolute reticulocyte measured in the knock-out mice than in the wild-
type mice. Sixth, human error is always a possibility for unexpected results: the 
counting of (muscularized) small pulmonary arteries and DNA damage in the 
endothelial cells was not entirely fool-proof and could be considered subjective by the 
counter. There was only one person who did the counting, so no confirmation could be 
made of the results.  
With these limitations in mind, a future study can be designed differently to test 
the same hypothesis for more reliable results. Rather than using the SCL-CreER 
transgenic line to delete the Mre11 gene in vascular endothelial cells, this study can take 
on a different method utilizing the vascular endothelium cadherin (VE-cadherin) 
promoter, which Alva et al. support by asserting that, in contrast to other endothelial 
cell-specific transgenic lines such as Tie-2-Cre and SCL-CreER, the use of VE-cadherin 
allows for expression of CreER-recombinase in endothelial cells that have become 
quiescent, or inactive, thus targeting adult endothelium (3). The structure of the study 
should include two sets of experiments: one set of 5 wild-type mice and 5 knock-out 
mice at 12 weeks of age in room air and another set of 5 wild-type and 5 knock-out 
mice in hypoxia at 10% O2 for 3 weeks and then in room air for 4 weeks of recovery, as 
was done in the study done by Guignabert et al. These additions serve the purpose of 
setting a baseline for the measurements taken in hypoxia and of observing whether 
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differences between the wild-type and knock-out mice remain manifest in the recovery 
period in the form of differences in amounts of DNA damage and/or worsened 
pulmonary vasculature. As part of the subsequent lung histology, a TUNEL (terminal 
deoxynucleotidyl transferase dUTP nick end labeling) assay typically used to assess 
apoptosis directly and DNA damage indirectly by labeling fragmented DNA can be 
carried out alongside with the immunohistochemistry identifying endothelial cells with 
DNA damage for confirmation of the quantified results I had obtained by counting 
endothelial cells with DNA damage using the γH2AX marker. For the analysis of the 
immunohistochemistry stainings and, if included, of the TUNEL assay results, there 
should be at least 3 people counting, and the results should be averaged. With these 
edits made to the study, it is possible that different results will be obtained to elucidate 
more clearly the progression of pulmonary arterial hypertension from DNA damage in 
endothelial cells to worsened pulmonary vasculature characteristic of the disease. 
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